Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology
Daniel M. Harrison(University of Maryland, Baltimore), Peter A. Calabresi(Johns Hopkins University), Jiwon Oh(St. Michael's Hospital), Snehashis Roy(Jackson Foundation), Michaela A. Seigo(Johns Hopkins University), Craig Jones(Johns Hopkins University), Daniel S. Reich(National Institutes of Health), Peter C.M. van Zijl(Kennedy Krieger Institute), Dzung L. Pham(University of Massachusetts Amherst), Emily T. Wood(National Institutes of Health), Anna Whetstone(Johns Hopkins University)
Cited by 67
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Longitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain
|Journal of Neuroscience|2003|1.4k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
|The Lancet|2011|743
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646